STEライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 05:00):

Stats
本日の出来高	306 277
平均出来高	488 947
時価総額	20.15B
EPS	$0 ( 2024-02-07 )
次の収益日	( $2.43 ) 2024-05-08
Last Dividend	$0.520 ( 2023-11-20 )
Next Dividend	$0 ( N/A )
P/E	35.83
ATR14	$0.119 (0.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-22	Kohler Kenneth E	Sell	0	Ordinary Shares
2024-02-22	Kohler Kenneth E	Sell	2 136	Employee Stock Options (right to buy)
2024-02-22	Kohler Kenneth E	Sell	3 728	Employee Stock Options (right to buy)
2024-02-22	Kohler Kenneth E	Sell	2 764	Employee Stock Options (right to buy)
2024-02-22	Kohler Kenneth E	Sell	4 100	Employee Stock Options (right to buy)

INSIDER POWER
54.14
Last 98 transactions
Buy: 253 331 \| Sell: 67 940

ボリューム相関

長: 0.27 (neutral)

短: -0.93 (very strong negative)

Signal:(40.213) Neutral

Steris plc 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Steris plc 相関 - 通貨/商品

-0.48
( neutral )

-0.26
( neutral )

0.00
( neutral )

-0.66
( moderate negative )

0.06
( neutral )

0.47
( neutral )

Steris plc 財務諸表

Annual	2023
収益:	$4.96B
総利益:	$2.16B (43.56 %)
EPS:	$1.070

FY	2023
収益:	$4.96B
総利益:	$2.16B (43.56 %)
EPS:	$1.070

FY	2022
収益:	$4.59B
総利益:	$2.02B (43.98 %)
EPS:	$2.50

FY	2021
収益:	$3.11B
総利益:	$1.34B (43.22 %)
EPS:	$4.66

Financial Reports:

No articles found.

Steris plc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.470 (N/A)	$0.470 (N/A)	$0.470 (N/A)	$0.470 (N/A)	$0.520 (N/A)	$0.520 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Steris plc Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.44 - Stable (11.29%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0400	2005-05-26
Last Dividend	$0.520	2023-11-20
Next Dividend	$0	N/A
Payout Date	2023-12-21
Next Payout Date	N/A
# dividends	75	--
Total Paid Out	$19.66	--
Avg. Dividend % Per Year	0.62%	--
Score	4.85	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.44
Div. Directional Score	7.86	--

Next Divdend (Est)
(2024-07-01)

$0.529 Estimate 39.86 %

Dividend Stability

0.80 Good

Dividend Score

4.85

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2005	$0.120	0.52%
2006	$0.170	0.67%
2007	$0.220	0.86%
2008	$0.280	0.97%
2009	$2.41	10.10%
2010	$0.520	1.84%
2011	$0.640	1.73%
2012	$0.720	2.39%
2013	$0.800	2.28%
2014	$0.880	1.86%
2015	$0.960	1.47%
2016	$1.060	1.43%
2017	$1.180	1.73%
2018	$1.300	1.47%
2019	$1.420	1.36%
2020	$1.540	1.02%
2021	$1.660	0.88%
2022	$1.800	0.74%
2023	$1.980	1.07%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.105	1.500	7.90	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0496	1.200	8.35	10.00	[0 - 0.3]
returnOnEquityTTM	0.0912	1.500	-0.0981	-0.147	[0.1 - 1]
payoutRatioTTM	0.345	-1.000	6.55	-6.55	[0 - 1]
currentRatioTTM	2.43	0.800	2.86	2.29	[1 - 3]
quickRatioTTM	1.269	0.800	7.24	5.79	[0.8 - 2.5]
cashRatioTTM	0.214	1.500	9.92	10.00	[0.2 - 2]
debtRatioTTM	0.307	-1.500	4.89	-7.33	[0 - 0.6]
interestCoverageTTM	5.90	1.000	8.92	8.92	[3 - 30]
operatingCashFlowPerShareTTM	9.46	2.00	6.85	10.00	[0 - 30]
freeCashFlowPerShareTTM	6.01	2.00	6.99	10.00	[0 - 20]
debtEquityRatioTTM	0.547	-1.500	7.81	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.436	1.000	6.07	6.07	[0.2 - 0.8]
operatingProfitMarginTTM	0.151	1.000	8.98	8.98	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.266	1.000	9.63	9.63	[0.2 - 2]
assetTurnoverTTM	0.473	0.800	-0.181	-0.145	[0.5 - 2]
Total Score				11.28

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	35.54	1.000	6.51	0	[1 - 100]
returnOnEquityTTM	0.0912	2.50	-0.0631	-0.147	[0.1 - 1.5]
freeCashFlowPerShareTTM	6.01	2.00	8.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.996	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	9.46	2.00	6.85	10.00	[0 - 30]
payoutRatioTTM	0.345	1.500	6.55	-6.55	[0 - 1]
pegRatioTTM	-0.621	1.500	-7.48	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.173	1.000	8.18	0	[0.1 - 0.5]
Total Score				4.44

Steris plc

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.